CYP2C9*3 gene variant contributes independently to glycaemic control in patients with type 2 diabetes treated with glibenclamide.
Journal of clinical pharmacy and therapeutics | 2018-12-01 | PMID 29802808
Castelán-Martínez O D, Hoyo-Vadillo C, Bazán-Soto T B and 3 more
Genes: ABCC8, KCNJ11
